VISA and VRSA cannot be successfully treated with<unk>  because these organisms are no longer susceptibile to<unk> . However, to date, all VISA and VRSA isolates have been susceptible to other Food and Drug Administration (FDA) approved drugs like trimethoprim/sulfamethoxazole, clindamycin, or ceftaroline.
Vancomycin-resistant Staphylococcus aureus medical therapy
Staphylococcus aureus infection medical therapy
Proteus infection medical therapy
Cutaneous abscess medical therapy
Endocarditis medical therapy
Opportunistic infection medical therapy
Pneumonia medical therapy
Escherichia coli infection medical therapy